Obesity Medications: Why 1 in 5 Patients May Not See Results

Obesity treatments using drugs like Ozempic and Wegovy have gained popularity in recent years. However, experts say that up to 20% of patients, or 1 in 5, may not see significant results. This is a growing concern as many people have high hopes for these medications.

Danielle Griffin, a 38-year-old IT worker from New Mexico, had access to these drugs without issue. Her pharmacy had them in stock, and her insurance covered most of the costs. Despite this, she found the medications did not work for her. After a year and a half on Wegovy, she lost only 13 pounds, despite following a healthy diet and exercising.

Clinical trials showed that most participants lose between 15% and 22% of their body weight using these drugs. Yet, 10% to 15% were “nonresponders,” losing less than 5% of their weight. Experts warn patients not to expect each medication to work the same for everyone.

Dr. Fatima Cody Stanford, an obesity expert, explains that people respond differently to these medications due to factors like genetics, hormones, and brain function. Conditions like sleep apnea and certain medications can also hinder weight loss.

Many patients face disappointment when they see little weight change after starting treatment. Dr. Katherine Saunders notes the emotional impact this leads to. Griffin, who aimed to lose 70 pounds, felt disheartened after minimal results.

What alternative treatment options are available for patients who do not respond to obesity medications like Ozempic and Wegovy?

Interview with Dr. Fatima Cody Stanford, Obesity Expert

News Directory 3: Thank you for joining us, Dr. Stanford. We’ve seen a surge in the popularity of obesity treatments like Ozempic and Wegovy, but there are significant concerns about their effectiveness in certain individuals. Can you elaborate on how these medications work and why they may not be effective for everyone?

Dr. Fatima Cody Stanford: Absolutely, and thank you for having me. Ozempic and Wegovy, both containing the active ingredient semaglutide, are designed to aid weight management by regulating appetite and enhancing glucose control. They prompt the body to release insulin while reducing feelings of hunger. However, it’s important to acknowledge that up to 20% of patients may be classified as “nonresponders,” meaning they experience minimal weight loss, often less than 5% of their body weight, despite adhering to the prescribed regimen.

News Directory 3: That’s concerning for patients who place high hopes on these medications. What factors contribute to this variability in response?

Dr. Stanford: Several factors play a role in how individuals respond to these treatments. Genetics is a significant factor—different genetic profiles can influence metabolism and weight loss. Additionally, hormones and brain function can affect how someone responds to appetite regulation. Other medical conditions, such as sleep apnea, and certain medications can impede weight loss efficacy. Thus, each patient’s unique biology dictates their experience with these drugs.

News Directory 3: Can you share the emotional impact on patients when they don’t see the desired results?

Dr. Katherine Saunders has noted the psychological toll this can take on individuals.

Dr. Stanford: Yes, Dr. Saunders is right; the emotional fallout can be quite profound. Many patients, like Danielle Griffin whom you mentioned, set specific weight loss goals, and when those aren’t met, it can lead to feelings of despair and hopelessness. It’s critical that healthcare providers offer support and realistic expectations regarding the outcomes from these medications.

News Directory 3: Speaking of support, how do you recommend patients approach their treatment plans, especially if they are not seeing results?

Dr. Stanford: A comprehensive approach is key. Patients should work closely with healthcare professionals to establish realistic goals and personalized plans that may include lifestyle modifications like diet and exercise alongside medication. If a patient is not experiencing significant weight loss, it is essential to reassess their treatment. Alternatives exist, such as switching medications or adjusting dietary and lifestyle habits, which can provide new pathways for success.

News Directory 3: Given that some patients do not respond to these medications, what should they consider next?

Dr. Jody Dushay emphasizes that exploring different treatment options can yield better results.

Dr. Stanford: That’s correct. For patients who experience minimal progress, exploring other medications or treatment paths is crucial. As you noted in Danielle’s case, transitioning to Zepbound, which works through a different hormonal pathway, led to positive outcomes for her. It underscores the importance of individualizing treatment plans in obesity management.

News Directory 3: Thank you, Dr. Stanford, for your insights. It’s clear that while medications like Ozempic and Wegovy can be effective for many, they are not a one-size-fits-all solution, and patients should be prepared to work closely with their healthcare teams to find the best approach for their specific needs.

Dr. Stanford: Exactly, and thank you for bringing attention to this important topic. By fostering communication and understanding between patients and healthcare professionals, we can address the complexities of obesity treatment more effectively.

These medications are often prescribed along with lifestyle changes. Doctors can determine within weeks if a patient will respond to the treatment. If weight loss does not occur, or if side effects become intolerable, patients may feel hopeless.

However, alternatives exist. Dr. Jody Dushay advises that trying a different medication or adjusting diet and lifestyle habits can help. Danielle began using Zepbound, which targets another hormone path, and has lost 7 pounds in three months.

In summary, while drugs like Ozempic and Wegovy can be effective, they do not work for everyone. Seeking guidance from healthcare professionals trained in obesity treatment can provide options and support. Obesity requires a comprehensive approach to ensure each patient finds what works for them.